Publications

P244 Planning services for people with type 2 diabetes: Is incidence still increasing

Published Date: 23rd March 2022

Publication Authors: Westall S, Mitchell L, Cardwell J, Furlong NJ, Narayanan RP, Bujawansa S, Balafshan T, Hardy KJ, McNulty S

Aims
Government plans for integrated care systems and integrated care boards are a welcome move towards more joined-up diabetes care between the NHS and local authorities, between health and social care and between specialist, community and primary care services. To plan effectively, for example, structured education for all newly diagnosed type 2 patients, we must not only know the widely publicised prevalence of type 2 diabetes, but also the incidence. The aim of this study was to establish the incidence of type 2 diabetes in a deprived, predominantly Caucasian northern borough.

Methods
Using GP electronic practice records, we compared the prevalence and monthly incidence of type 2 diabetes, April-October 2019, 2020 and 2021.

Results
The GP-registered adult population of the borough was: 158,860 in April 2019, 151,819 in April 2020 and in 152,974 April 2021 and the prevalence of diabetes was stable: 8.07%, 8.08% and 8.07% respectively (slightly higher than England as a whole). Using these population figures as the denominator, in 2019, monthly incidence of type 2 diabetes varied from 33 to 81, mean 54 new cases, giving an incidence of 0.34/1000/month; in 2020, type 2 incidence varied from 16 to 63, mean 42 cases, giving an incidence of 0.28/1000/month and in 2021, type 2 incidence varied from 45 to 85, mean 63, giving an incidence of 0.41/1000/month.

Summary
These data suggest that the monthly incidence of type 2 diabetes varies, but that for planning purposes probably lies in the range 0.34–0.41 new cases/1000 population/month.

 

Fullerton, H; Westall, SJ; Mitchell, L; Cardwell, J; McNulty, S; Furlong, N; Narayanan, RP; Buawansa, S; Balafshan, T; Hardy, KJ. (2022). P244 Planning services for people with type 2 diabetes: Is incidence still increasing. Diabetic Medicine. 39 (Suppl 1), 127

 

 

« Back